T cells with increased expression of malic enzyme 1 and uses thereof in cancer therapy
AssigneeMayo Foundation for Medical Education and Research
InventorsHaidong Dong, Joanina K. Gicobi
Life of this patent
Estimating the term…
Abstract
Methods and materials for increasing expression of malic enzyme 1 (ME1) in T cells are provided herein, as are compositions containing ME1 coding sequences or ME1 mRNA, and methods and materials for using T cells with increased ME1 levels to treat mammals having cancer.
Claims29
A method for increasing a level of malic enzyme 1 (ME1) in a cell, said method comprising:
- introducing into said cell a nucleic acid encoding ME1, and
- incubating said cell such that said nucleic acid is expressed, thereby increasing the level of ME1 in said cell.
3-7. (canceled)
A method for treating a mammal, said method comprising administering to said mammal a composition comprising cells that comprise an exogenous nucleic acid encoding ME1, such that said cells have an elevated level of ME1.
12-13. (canceled)
15-19. (canceled)
A composition comprising PBMCs that comprise an exogenous nucleic acid encoding ME1.
22-26. (canceled)
A method for increasing a level of a polypeptide having malic enzyme 1 (ME1) activity in a cell, wherein said method comprises:
- (a) introducing into said cell a nucleic acid encoding said polypeptide, and
- (b) incubating said cell such that said nucleic acid is expressed, thereby increasing the level of said polypeptide in said cell.
28-30. (canceled)
32-34. (canceled)
A method for treating a mammal, wherein said method comprises administering to said mammal a composition comprising cells comprising an exogenous nucleic acid that encodes a polypeptide having ME1 activity, wherein said cells have an elevated level of said polypeptide.
36-38. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.